Global HealthPharmaceutical Regulations in Japan

Cooperation with Stakeholders

Joint Statement (July 2012)

JPMA published a joint statement on internet sales and access to safe medicines with the other major pharmaceutical industry associations, IFPMA, PhRMA and EFPIA. The associated material is available externally via the following links.

Furthermore, the IFPMA, in cooperation with the Fondation Chirac, International Council of Nurses (ICN), International Institute of Research Against Counterfeit Medicines (IRACM), Medicines for Malaria Venture (MMV), NCD Alliance, U.S. Pharmacopeial Convention (USP), World Medical Association (WMA), and the World Heart Federation, is conducting the “Fight the Fakes”campaign, and the JPMA is also supporting this initiative.

JPMA Media Forum (The Current State of Counterfeit Medicines and Public-Private-Academia Initiatives for Countermeasures)

Under the theme of “The Current State of Counterfeit Medicines and Public-Private-Academia Initiatives for Countermeasures”, a JPMA Media Forum was held on February 17, 2014 with 30 members of the press in attendance.

Collaboration with INTERPOL

Twenty-nine global pharmaceutical companies have given funding to INTERPOL for its efforts to combat counterfeit medicines (including raising awareness, exposing counterfeiters and distributors, capacity building for discovery of counterfeit medicines). JPMA member companies who are participating in this initiative include Astellas, Chugai, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Otsuka, Shionogi and Takeda.

Page Top

  • Office of Pharmaceutical Industry Research(OPIR)
  • Global Health
  • Stop AMR
  • APAC